Skip to content

Indivior Pharmaceuticals, Inc. INDV Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$175M-53.0%$195M-38.9%$445M+54.5%$510M$372M
$1.03B+106%$995M+296%$996M+297%$728M+171%$498M+86.9%
$21M-41.7%$32M-37.3%$40M-76.0%$45M-72.3%$36M-76.9%
$667M$652M$922M
$157M$144M$124M
$2M$2M$2M
$1.2B$1.2B$1.42B
$35M$48M$41M
$0$29M$18M
$779M$914M$965M
$486M$290M$304M
$1.34B$1.3B$1.62B
$0$62M$62M
-$280M-$243M-$346M
-$144M+49.5%-$98M+70.9%-$207M+33.2%-$257M-$285M
$1.2B$1.2B$1.42B

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Indivior Pharmaceuticals, Inc. cover its short-term obligations?
Its current ratio is 0.86 — current liabilities exceed current assets.
Where does Indivior Pharmaceuticals, Inc. 's balance sheet data come from?
Every line is extracted from Indivior Pharmaceuticals, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.